Light Sensitization Study

Sleep Disorders, Circadian Rhythm Clinical Trial

Official title:

Sensitization of Human Circadian Responses to Light

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01327040
• Other study ID #: 2010-P-000346
• Secondary ID: R01HL094654
• Status: Completed
• Phase: N/A
• Start date: October 2010
• Est. completion date: December 2020

Study information

• Verified date: June 2021
• Source: Brigham and Women's Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Circadian rhythm disorders are a class of sleep disorders characterized by misalignment between the timing of sleep and the timing of rhythms driven by the biological clock. Light therapy can effectively treat these disorders, but the intensity and duration of light exposure required to do so has limited its practical use. In this study the investigators will test whether pre-exposure to dim light may enhance the response of the circadian system to light therapy. If so, this could result in shorter treatments that would have greater practical applications.

Description:

Sleep disorders affect 35-40% of adults, resulting in diminished quality of life, and increased morbidity, mortality, and risk of automobile and occupational accidents. Circadian rhythm sleep disorders form a distinct class of sleep disorders characterized by misalignment between the timing of sleep and the circadian pacemaker. While light therapy can be an effective treatment of circadian rhythm sleep disorders, there are numerous practical limitations. Light is the most powerful signal from the environment that influences and regulates daily biological rhythms. It is well-established that the irradiance, duration, and timing of light exposure all affect the response of the circadian system. While it was once thought that these responses were mediated through the visual system, it is now known that there is a network of intrinsically photosensitive retinal ganglion cells (ipRGCs) that mediate circadian responses to light. Other new studies have demonstrated that recent light exposure history affects the circadian response to light in humans. These recent findings have important implications for the use of light to treat circadian rhythm disorders, including delayed and advanced sleep phase disorders, shift work sleep disorder, and jet lag, and they may also have relevance for the use of light to treat seasonal affective disorder. Up to now, little attention has been paid to the duration or intensity of light exposure prior to such light treatments. The investigators now have evidence that the human circadian system can become desensitized to light during long exposures and evidence that it can be sensitized to light by prior exposure to dim light. These recent findings suggest that light treatment protocols that sensitize the circadian system prior to the light treatment will be more effective than those currently in use. The 13-day inpatient studies the investigators propose will examine the effect on the human circadian system of different durations of dim-light sensitization prior to a standardized light treatment. These results will be compared within subjects in a randomized cross-over design study in which each subject will receive a control treatment and a light treatment with prior dim-light sensitization. The investigators will also include circadian phase disorder patients to test these mechanisms in the target patient population. Our findings will provide an important step in understanding how new knowledge about the circadian photoreceptive system can be used to refine and provide better treatment options for circadian rhythm disorders.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 32
• Est. completion date: December 2020
• Est. primary completion date: December 2015
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 21 Years to 30 Years

Eligibility

Inclusion Criteria:

• healthy adults with conventional and regular sleep-wake timing
• non-smokers
• completion of medical, psychological, ophthalmological, and sleep screening tests
• able to spend 13 consecutive days/nights in the laboratory

Exclusion Criteria:

• history of neurological or psychiatric disorder
• history of eye injury, eye surgery, or visual disorder (corrective lenses are acceptable)
• history of sleep disorder or regular use of sleep-promoting medication
• current prescription, herbal, or over-the-counter medication use (oral contraceptives are acceptable)

Related Conditions & MeSH terms

• Chronobiology Disorders
• Circadian Rhythm Disorders
• Disease
• Sleep Disorders, Circadian Rhythm
• Sleep Wake Disorders

Intervention

Other:
• light exposure
12-hour light exposure of approximately 200 lux

Locations

Country	Name	City	State
United States	Brigham and Women's Hospital	Boston	Massachusetts

Sponsors (2)

Lead Sponsor	Collaborator
Brigham and Women's Hospital	National Heart, Lung, and Blood Institute (NHLBI)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	circadian phase timing	timing of circadian phase as assessed using melatonin and temperature data	During inpatient study, on days 6-7 and 11-12
Secondary	melatonin suppression	percent of melatonin suppression	During inpatient study, on days 6-7 and 11-12